Angiodynamics (ANGO) Divestments (2023 - 2024)
Angiodynamics (ANGO) posted Divestments of $34.5 million for Q1 2024, down 65.5% on a QoQ basis from $100.0 million in Q3 2023.
Angiodynamics (ANGO) Divestments (2023 - 2024) Analysis & Trends
Angiodynamics' Divestments history runs 2 years deep, the most recent figure standing at $34.5 million for Q1 2024.
- Quarterly Divestments changed N/A year-over-year to $34.5 million in Q1 2024, while the trailing twelve-month figure through Nov 2024 was $34.5 million (down 65.5% YoY) and the FY2024 annual result came in at $134.5 million, changed N/A from the prior year.
- Divestments was $34.5 million for Q1 2024 at Angiodynamics, down from $100.0 million in the prior quarter.
- Across five years, Divestments topped out at $100.0 million in Q3 2023 and bottomed at $34.5 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Angiodynamics | 558.11 Mn | 504.25 Mn | 46.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 29, 2024 | 34.50 Mn |
| Aug 31, 2023 | 100.00 Mn |